Remick DG - Search Results

1

Differential expression of tumor necrosis factor and interleukin-6 by peritoneal macrophages in vivo and in culture.

Wollenberg GK, DeForge LE, Bolgos G, Remick DG. Wollenberg GK, et al. Among authors: remick dg. Am J Pathol. 1993 Oct;143(4):1121-30. Am J Pathol. 1993. PMID: 8214006 Free PMC article.

2

Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture.

Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G. Remick D, et al. Shock. 1995 Aug;4(2):89-95. doi: 10.1097/00024382-199508000-00002. Shock. 1995. PMID: 7496903

3

Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.

Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG. Eskandari MK, et al. Among authors: remick dg. J Immunol. 1992 May 1;148(9):2724-30. J Immunol. 1992. PMID: 1315357

4

Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood.

DeForge LE, Fantone JC, Kenney JS, Remick DG. DeForge LE, et al. Among authors: remick dg. J Clin Invest. 1992 Nov;90(5):2123-9. doi: 10.1172/JCI116097. J Clin Invest. 1992. PMID: 1331181 Free PMC article.

5

Profile of cytokines in synovial fluid specimens from patients with arthritis. Interleukin 8 (IL-8) and IL-6 correlate with inflammatory arthritides.

Remick DG, DeForge LE, Sullivan JF, Showell HJ. Remick DG, et al. Immunol Invest. 1992 Jul;21(4):321-7. doi: 10.3109/08820139209069371. Immunol Invest. 1992. PMID: 1398781

6

Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide-stimulated human whole blood.

DeForge LE, Tracey DE, Kenney JS, Remick DG. DeForge LE, et al. Among authors: remick dg. Am J Pathol. 1992 May;140(5):1045-54. Am J Pathol. 1992. PMID: 1533750 Free PMC article.

7

Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies.

DeForge LE, Kenney JS, Jones ML, Warren JS, Remick DG. DeForge LE, et al. Among authors: remick dg. J Immunol. 1992 Apr 1;148(7):2133-41. J Immunol. 1992. PMID: 1545121

8

Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood.

DeForge LE, Remick DG. DeForge LE, et al. Among authors: remick dg. Biochem Biophys Res Commun. 1991 Jan 15;174(1):18-24. doi: 10.1016/0006-291x(91)90478-p. Biochem Biophys Res Commun. 1991. PMID: 1989598 Free article.

9

Cyclosporin a modulation of tumor necrosis factor gene expression and effects in vitro and in vivo.

Nguyen DT, Eskandai MK, DeForge LE, Raiford CL, Strieter RM, Kunkel SL, Remick DG. Nguyen DT, et al. Among authors: remick dg. J Immunol. 1990 May 15;144(10):3822-8. J Immunol. 1990. PMID: 2159035

10

Regulation of the pathophysiology of tumor necrosis factor.

DeForge LE, Nguyen DT, Kunkel SL, Remick DG. DeForge LE, et al. Among authors: remick dg. J Lab Clin Med. 1990 Oct;116(4):429-38. J Lab Clin Med. 1990. PMID: 2212853 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters